A pharmacological approach to the treatment of anorexia nervosa (AN) is suggested. The hypothalamic-pituitary-adrenal (HPA) axis maintains AN pathophysiology. Insular and frontal functions generate negative emotions in patients with AN. Mifepristone (RU486) may counteract these mechanisms improving symptoms of AN.